Urgency assessment in the evaluation of overactive bladder (OAB)

Neurourology and Urodynamics

Volumn 27, Issue 1, 2008, Pages 13-21

  Starkman, Jonathan S ^a   Dmochowski, Roger R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bladder; Incontinence; Overactive bladder; Urgency

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EXAMINATION; DISEASE SEVERITY; HUMAN; MEASUREMENT; MICTURITION; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; URINARY URGENCY; URINE INCONTINENCE; URODYNAMICS; VISUAL ANALOG SCALE;

HUMANS; PROGNOSIS; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE;

EID: 37849004330     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20472     Document Type: Review

References (69)

1. Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001;87:760-6.
2. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20: 327-36.
3. Hu TW, Wagner TH, Bentkover JD, et al. Estimated economic costs of overactive bladder in the United States. Urology 2003;61:1123-8.
4. Coyne KS, Payne C, Bhattacharyya SK, et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: Results from a national community survey. Value Health 2004;7: 455-63.
5. Tubaro A. Defining overactive bladder: Epidemiology and burden of disease. Urology 2004;64:2-6.
6. Abrams P, Wein AJ. The overactive bladder: From basic science to clinical management. Urology 1997;50:1-144.
7. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
8. Abrams P, Blaivas JG, Stanton SL, et al. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl 1988;114: 5-19.
9. Abrams P. Urgency: The key to defining the overactive bladder. BJU Int 2005;96:1-3.
10. Athwal BS, Berkley KJ, Hussain I, et al. Brain responses to changes in bladder volume and urge to void in healthy men. Brain 2001;124:369-77.
11. de Groat WC. A neurologic basis for the overactive bladder. Urology 1997;50:36-52; discussion 53-6.
12. Drake MJ, Harvey IJ, Gillespie JI, et al. Localized contractions in the normal human bladder and in urinary urgency. BJU Int 2005;95:1002-5.
13. Turner WH, Brading AF. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacol Ther 1997;75:77-110.
14. Coolsaet BL, Van Duyl WA, Van Os-Bossagh P, et al. New concepts in relation to urge and detrusor activity. Neurourol Urodyn 1993;12: 463-71.
15. de Groat WC. The urothelium in overactive bladder: Passive bystander or active participant? Urology 2004;64:7-11.
16. Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 2001;358:401-3.
17. Gillespie JI. A developing view of the origins of urgency: The importance of animal models. BJU Int 2005;96:22-8.
18. Brubaker L. Urinary urgency and frequency: What should a clinician do? Obstet Gynecol 2005;105:661-7.
19. Abrams P, Artibani W, Cardozo L, et al. Reviewing the ICS 2002 Terminology Report: The Ongoing Debate. Neurourol Urodyn 2006;25:293.
20. Brubaker L. Urgency: The cornerstone symptom of overactive bladder. Urology 2004;64:12-6.
21. Abrams P. Overactive bladder. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. Philadelphia: Elsevier; 2007. pp 2079-91.
22. Wyndaele JJ, De Wachter S. Cystometrical sensory data from a normal population: Comparison of two groups of young healthy volunteers examined with 5 years interval. Eur Urol 2002;42:34-8.
23. Cardozo L, Prescott K, Serdarevic D, et al. Can medication prolong warning time? Florence, Italy, 2003.
24. Larsson G, Victor A. Micturition patterns in a healthy female population, studied with a frequency/volume chart. Scand J Urol Nephrol Suppl 1988; 114:53-7.
25. Chapple CR, Artibani W, Cardozo LD, et al. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: Current concepts and future prospects. BJU Int 2005;95:335-40.
26. Blaivas JG, Panagopoulos G, Weiss JP, et al. The urgency perception score: Validation and test-retest. J Urol 2007;177:199-202.
27. Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome - overactive bladder symptom score. Urology 2006;68: 318-23.
28. Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q. Qual Life Res 2002;11:563-74.
29. Coyne KS, Matza LS, Thompson C, et al. The responsiveness of the OAB-q among OAB patient subgroups. Neurourol Urodyn 2007;26:196-203.
30. Coyne KS, Matza LS, Thompson CL. The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res 2005;14:849-55.
31. Matza LS, Thompson CL, Krasnow J, et al. Test-retest reliability of four questionnaires for patients with overactive bladder: The overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn 2005;24:215-25.
32. Shaw C, Matthews RJ, Perry SI, et al. Validity and reliability of an interviewer-administered questionnaire to measure the severity of lower urinary tract symptoms of storage abnormality: The Leicester Urinary Symptom Questionnaire. BJU Int 2002;90:205-15.
33. Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms questionnaire: Development and psychometric testing. Br J Urol 1996;77:805-12.
34. Abrams P, Avery K, Gardener N, et al. The International Consultation on Incontinence Modular Questionnaire: www.iciq.net. J Urol 2006:175:1063-66; discussion 1066.
35. Barry MJ, Fowler FJ, Jr., O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57; discussion 1564.
36. Scarpero HM, Fiske J, Xue X, et al. American Urological Association Symptom Index for lower urinary tract symptoms in women: Correlation with degree of bother and impact on quality of life. Urology 2003;61: 1118-22.
37. Ghei M, Malone-Lee J. Using the circumstances of symptom experience to assess the severity of urgency in the overactive bladder. J Urol 2005;174: 972-76.
38. Brown JS, McNaughton KS, Wyman JF, et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology 2003;61:802-9.
39. De Wachter S, Wyndaele JJ. Frequency-volume charts: A tool to evaluate bladder sensation. Neurourol Urodyn 2003;22:638-42.
40. Liatsikos EN, Hom D, Dinlenc CZ, et al. Tail stent versus re-entry tube: A randomized comparison after percutaneous stone extraction. Urology 2002; 59:15-9.
41. Srivastava A, Gupta R, Kumar A, et al. Routine stenting after ureteroscopy for distal ureteral calculi is unnecessary: Results of a randomized controlled trial. J Endourol 2003;17:871-4.
42. Frazer MI, Haylen BT, Sutherst JR. The severity of urinary incontinence in women. Comparison of subjective and objective tests. Br J Urol 1989;63: 14-5.
43. Frazer MI, Sutherst JR, Holland EF. Visual analogue scores and urinary incontinence. Br Med J (Clin Res Ed) 1987;295:582.
44. Simons AMDC, Bryant CM. Visual analog scale for incontinence impact. Aust Continence J 1998;4:67-8.
45. Yoong WSA, Allen W, Moore K. Visual analog scores for urinary incontinence. Neurourol Urodyn 2000;19:453-5.
46. Lukacz ES, Lawrence JM, Burchette RJ, et al. The use of Visual Analog Scale in urogynecologic research: A psychometric evaluation. Am J Obstet Gynecol 2004;191:165-70.
47. Coyne K, Matza LS, Versi E. Urinary urgency: Can "gotta go" be measured? Poster presented at the 10th Annual Meeting of the International Society for Quality of Life Research, Prague, Czech Republic, 2003.
48. Freeman RM. How urgent is urgency? A review of current methods of assessment. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:93-5.
49. Erdem E, Akbay E, Doruk E, et al. How reliable are bladder perceptions during cystometry? Neurourol Urodyn 2004;23:306-9; discussion 310.
50. Erdem E, Tunckiran A, Acar D, et al. Is catheter cause of subjectivity in sensations perceived during filling cystometry? Urology 2005;66:1000-3; discussion 1003-4.
51. Rosier P, Bosch JR. A prospective study to find evidence of the ICS definition of urgency. Presented at the ICS annual meeting, November 2006, Christchurch, New Zealand.
52. Oliver S, Fowler C, Mundy A, et al. Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation. Neurourol Urodyn 2003;22:7-16.
53. Oliver S, Susser J, Fowler C, et al. Validation of an objective measure for bladder sensations and urge perceived by patients with detrusor instability during filling cystometrograms. Br J Urol 2000;86:371.
54. Wyndaele JJ. The normal pattern of perception of bladder filling during cystometry studied in 38 young healthy volunteers. J Urol 1998;160: 479-81.
55. Griffiths D. Editorial Comment, Re: Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation. Neurourol Urodyn 2003;22:16.
56. Moore JA, Noble JG, Brading AF. Urgemeter cystometry - urodynamic assessment of urgency and the relationship of urge to detrusor overactivity. BJU Int 2004;93(suppl. 4):1-16.
57. Barber MD. Questionnaires for women with pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:461-5.
58. Coyne KS, Tubaro A, Brubaker L, et al. Development and validation of patient-reported outcomes measures for overactive bladder: A review of concepts. Urology 2006;68:9-16.
59. Michel MC, Oelke M, Goepel M, et al. Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients. Neurourol Urodyn 2007;26:190-5.
60. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products. Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence in Women. November 2001.
61. Coyne KS, Matza LS, Thompson C, et al. A comparison of three approaches to analyze urinary urgency as a treatment outcome; Montreal, Quebec, Canada, 2005.
62. Cardozo L, Coyne KS, Versi E. Validation of the urgency perception scale. BJU Int 2005;95:591-6.
63. Siami P, Seidman LS, Lama D. A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT). Clin Ther 2002;24: 616-28.
64. Van Kerrebroeck P, Kreder K, Jonas U, et al. Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder. Urology 2001;57:414-21.
65. Freeman R, Hill S, Millard R, et al. Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine. Obstet Gynecol 2003;102:605-11.
66. Nixon A, Colman S, Sabounjian L, et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005;174:604-7.
67. Zinner N, Harnett M, Sabounjian L, et al. The overactive bladder-symptom composite score: A composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J Urol 2005;173:1639-43.
68. Cardozo L, Dixon A. Increased warning time with darifenacin: A new concept in the management of urinary urgency. J Urol 2005;173:1214-8.
69. Wein AJ. Urgency: The cornerstone symptom of overactive bladder. J Urol 2005;173:2054.